Purchase Order 75D30122P13623
Award Date 4/5/22
Potential Completion Date 9/30/22
Potential Value $120K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for reagents to be used with Illumina's sequencing systems. The $219,192.00 contract does not have a set-aside designation and is intended to support the CDC's needs through August 31, 2022. Illumina has a history of providing sequencing equipment, consumables, and services to...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, for ILLUMINA ISEQ 100 I1 REAGENT. The potential value of this contract is $9,991.97. This award is not associated with any larger contract vehicle and does not have a set-aside designation. Illumina has previously provided sequencing systems, reagents,...
- The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $247,008.03 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract is for the provision of laboratory supplies, with a completion date of May 31, 2024. Illumina has previously received federal awards from agencies such as the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $241,046.40 firm fixed-price purchase order to Illumina, Inc. to provide reagents and supplies. The award has no set-aside designation. Illumina is a manufacturer and provider of genetic sequencing instruments and analytical products. This award aligns with Illumina's past prime federal contracts to support genomic sequencing and analysis for various government agencies including the CDC,...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the procurement of a NEXTSEQ 1000 SEQUENCING SYSTEM. The total potential value of the award is $205,800.00 with a completion date of August 23, 2021. Illumina has a history of providing sequencing equipment, consumables, and services to federal agencies such as the National...
- This is a $80,453.34 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing products and services. The contract is for the provision of reagent products to support the CDC's genomic sequencing and analysis work. Illumina has a history of providing sequencing systems, reagents, and related services to federal agencies like the NIH, USDA, and VA for research and diagnostics. This award does not have...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, for the provision of lab supplies and reagents. The $149,220.97 contract does not have a set-aside designation and is intended to support the CDC's research and diagnostics needs in Atlanta, Georgia. Illumina has a history of providing a range of...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $22,376.85 contract is for the provision of an ISEQ 100 SYSTEM, with a completion date of March 1, 2026. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...
- This firm fixed price BPA call was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $120,017.07 award is for Illumina's genomic sequencing solutions, including NextSeq, NovaSeq, MiSeq, and iSeq systems, to support the CDC's research and diagnostic needs. Illumina has previously provided sequencing platforms and services to other federal agencies...
- The Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order to Illumina, Inc. for $128,657.11 to provide whole genome sequencing kits. The award has an ultimate completion date of September 30, 2024. This award was made under an unrestricted solicitation, RFQ 75D301-24-Q-77983, which sought commercial items related to whole genome sequencing for antimicrobial resistance surveillance, including NovaSeq 6000 SP Reagent Kits, NovaSeq XP 2-Lane Kits, ILMN DNA LP...